Non-isotopic analysis of single strand conformation polymorphism (SSCP) in the exon 13 region of the human dystrophin gene.

More than 30% of Duchenne and Becker muscular dystrophy (DMD/BMD) patients have no gross DNA rearrangements like deletions or duplications. The large size of the coding sequence of the dystrophin gene (11 kilobases) complicates systematic identification of point mutations. Recently reported approaches based on genomic DNA or mRNA show that chemical cleavage of mismatches is an effective but time consuming and technically demanding method for the identification of point mutations in the human dystrophin gene. We have used a fast and convenient system consisting of PCR amplification of genomic DNA, non-isotopic SSCP analysis, and direct sequencing of PCR products for the detection of mutations in exon 13 and adjacent intron sequences. Sixty-eight DMD patients without detectable deletions or duplications were analysed, resulting in the identification of a point mutation in the coding sequence and two polymorphisms in the 5' flanking intron. The C to T change of the first nucleotide in the third triplet leads to a stop codon and seems to be the cause of the functional deficiency of the gene product in this patient.

[1]  A. Speer,et al.  Alternative splicing of dystrophin mRNA complicates carrier determination: report of a DMD family. , 1993, Journal of medical genetics.

[2]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Hayashi,et al.  PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. , 1991, PCR methods and applications.

[4]  K. Hayashi.  PCR-SSCP: a method for detection of mutations. , 1992, Genetic analysis, techniques and applications.

[5]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[6]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[7]  H. Davies,et al.  Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. , 1992, Human molecular genetics.

[8]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[9]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[10]  G. Puca,et al.  Detection of a nonsense mutation in the dystrophin gene by multiple SSCP. , 1992, Human molecular genetics.

[11]  M Krawczak,et al.  The effect of replication errors on the mismatch analysis of PCR-amplified DNA. , 1990, Nucleic acids research.

[12]  W. Böcker,et al.  Non-isotopic detection of single strand conformation polymorphism (PCR-SSCP): a rapid and sensitive technique in diagnosis of phenylketonuria. , 1991, Nucleic acids research.

[13]  D. Muzny,et al.  Scanning detection of mutations in human ornithine transcarbamoylase by chemical mismatch cleavage. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Bulman,et al.  Point mutation in the human dystrophin gene: identification through western blot analysis. , 1991, Genomics.

[15]  D. Bentley,et al.  Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR. , 1992, Genomics.

[16]  L. Surh,et al.  Diagnostic single strand conformational polymorphism, (SSCP): a simplified non-radioisotopic method as applied to a Tay-Sachs B1 variant. , 1991, Nucleic acids research.

[17]  Detection of DNA aberrations in human cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1991, The Tohoku journal of experimental medicine.

[18]  R. D. Campbell,et al.  Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Meitinger,et al.  Mutations in the candidate gene for Norrie disease. , 1992, Human molecular genetics.

[20]  C. Theillet,et al.  Protocols for an improved detection of point mutations by SSCP. , 1991, Nucleic acids research.

[21]  R. Eeles,et al.  Detection of point mutations in the p53 gene: Comparison of single‐strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques , 1993, Human mutation.

[22]  K. Davies,et al.  Preferential deletion of exons in Duchenne and Becker muscular dystrophies , 1987, Nature.

[23]  K. Davies,et al.  Human X chromosome markers and Duchenne muscular dystrophy. , 1985, Nucleic acids research.

[24]  W. J. Martin,et al.  Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. , 1991, Nucleic acids research.